Developing new cancer treatment tools, using imaging techniques such as PET-CT and MRI, and new radiopharmaceuticals for next-generation personalized therapies (“Theranostics”) to target cancer first at the “diagnosis” phase and then at the “therapy” phase, using the same biological targets (“see to treat”).
Sperm Banks Lack Diverse Donors for Diverse Recipients
NEW ORLEANS — There aren’t enough sperm donors of diverse backgrounds for diverse recipients, and the racial breakdown of donors doesn’t match the U.S. male
October 21, 2023